Biotechnologists harness biological systems, organisms, and cellular components to develop products and technologies that improve health, agriculture, and industry. Their work spans genetic engineering, microbiology, cell culture, and bioinformatics, with applications ranging from creating more efficient crops to producing life-saving pharmaceuticals. By manipulating DNA and proteins, biotechnologists contribute to advancements in medicine, such as personalized therapies, regenerative treatments, and targeted drug delivery systems. Their efforts also play a major role in industrial biotechnology, helping to create environmentally friendly alternatives like biodegradable plastics and biofuels.
Collaboration is key to the success of biotechnologists, as they work closely with molecular biologists, chemical engineers, and data scientists to bring innovations from the lab to the real world. In the healthcare sector, they develop and refine diagnostic tools, therapeutic proteins, and vaccine technologies that are essential to modern medicine. Their involvement in research and development accelerates the pipeline from scientific discovery to commercial application, ensuring that innovations reach those who need them most. Moreover, biotechnologists contribute to food security and environmental sustainability by engineering drought-resistant crops and bio-remediation techniques. Their versatile skill set and interdisciplinary approach position them as key players in addressing global challenges. With science evolving rapidly, biotechnologists continue to shape a more sustainable, healthy, and innovative future.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy